115 related articles for article (PubMed ID: 38700461)
21. Evidence-Based Process Performance Measures and Clinical Outcomes in Patients With Incident Heart Failure With Reduced Ejection Fraction: A Danish Nationwide Cohort Study.
Schjødt I; Johnsen SP; Strömberg A; DeVore AD; Valentin JB; Løgstrup BB
Circ Cardiovasc Qual Outcomes; 2022 Apr; 15(4):e007973. PubMed ID: 35272503
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of medical therapy in patients with heart failure with reduced ejection fraction.
Kocabaş U; Ergin I; Kıvrak T; Yılmaz Öztekin GM; Tanık VO; Özdemir İ; Avcı Demir F; Doğduş M; Şen T; Altınsoy M; Üstündağ S; Urgun ÖD; Sinan ÜY; Uygur B; Yeni M; Özçalık E
ESC Heart Fail; 2023 Dec; 10(6):3677-3689. PubMed ID: 37804042
[TBL] [Abstract][Full Text] [Related]
23. Estimated 5-Year Number Needed to Treat to Prevent Cardiovascular Death or Heart Failure Hospitalization With Angiotensin Receptor-Neprilysin Inhibition vs Standard Therapy for Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of Data From the PARADIGM-HF Trial.
Srivastava PK; Claggett BL; Solomon SD; McMurray JJV; Packer M; Zile MR; Desai AS; Rouleau JL; Swedberg K; Fonarow GC
JAMA Cardiol; 2018 Dec; 3(12):1226-1231. PubMed ID: 30484837
[TBL] [Abstract][Full Text] [Related]
24. Frailty according to the 2019 HFA-ESC definition in patients at risk for advanced heart failure: Insights from the HELP-HF registry.
Villaschi A; Chiarito M; Pagnesi M; Stolfo D; Baldetti L; Lombardi CM; Adamo M; Loiacono F; Sammartino AM; Colombo G; Tomasoni D; Inciardi RM; Maccallini M; Gasparini G; Montella M; Contessi S; Cocianni D; Perotto M; Barone G; Merlo M; Vitale C; Rosano GMC; Cappelletti AM; Sinagra G; Metra M; Pini D
Eur J Heart Fail; 2024 Jun; 26(6):1399-1407. PubMed ID: 38741569
[TBL] [Abstract][Full Text] [Related]
25. Frailty alone and interactively with obesity predicts heart failure: Kuopio Ischaemic Heart Disease Risk Factor Study.
Tajik B; Voutilainen A; Sankaranarayanan R; Lyytinen A; Kauhanen J; Lip GYH; Tuomainen TP; Isanejad M
ESC Heart Fail; 2023 Aug; 10(4):2354-2361. PubMed ID: 37165564
[TBL] [Abstract][Full Text] [Related]
26. Titration of medications and outcomes in multi-ethnic heart failure cohorts (with reduced ejection fraction) from Singapore and New Zealand.
Teng TK; Tay WT; Ouwerkerk W; Tromp J; Richards AM; Gamble G; Greene SJ; Yiu KH; Poppe K; Ling LH; Lund M; Sim D; Devlin G; Loh SY; Troughton R; Ren QW; Jaufeerally F; Lee SGS; Tan RS; Soon DKN; Leong G; Ong HY; Yeo DPS; Lam CSP; Doughty RN
ESC Heart Fail; 2023 Apr; 10(2):1280-1293. PubMed ID: 36722315
[TBL] [Abstract][Full Text] [Related]
27. The Association of Unmet Palliative Care Needs and Physical Frailty With Clinical Outcomes: A Prospective Study of Adults With Heart Failure.
DeGroot L; Pavlovic N; Perrin N; Gilotra NA; Miller H; Denfeld QE; McIlvennan CK; Dy SM; Davidson PM; Szanton SL; Abshire Saylor M
J Cardiovasc Nurs; 2024 Apr; ():. PubMed ID: 38635901
[TBL] [Abstract][Full Text] [Related]
28. Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction.
Butler J; Yang M; Manzi MA; Hess GP; Patel MJ; Rhodes T; Givertz MM
J Am Coll Cardiol; 2019 Mar; 73(8):935-944. PubMed ID: 30819362
[TBL] [Abstract][Full Text] [Related]
29. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
[TBL] [Abstract][Full Text] [Related]
30. Comparative Effectiveness of Sacubitril-Valsartan Versus ACE/ARB Therapy in Heart Failure With Reduced Ejection Fraction.
Tan NY; Sangaralingham LR; Sangaralingham SJ; Yao X; Shah ND; Dunlay SM
JACC Heart Fail; 2020 Jan; 8(1):43-54. PubMed ID: 31838035
[TBL] [Abstract][Full Text] [Related]
31. Optimal Pharmacologic Treatment of Heart Failure With Preserved and Mildly Reduced Ejection Fraction: A Meta-analysis.
Xiang B; Zhang R; Wu X; Zhou X
JAMA Netw Open; 2022 Sep; 5(9):e2231963. PubMed ID: 36125813
[TBL] [Abstract][Full Text] [Related]
32. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial.
Fiuzat M; Ezekowitz J; Alemayehu W; Westerhout CM; Sbolli M; Cani D; Whellan DJ; Ahmad T; Adams K; Piña IL; Patel CB; Anstrom KJ; Cooper LS; Mark D; Leifer ES; Felker GM; Januzzi JL; O'Connor CM
JAMA Cardiol; 2020 Jul; 5(7):757-764. PubMed ID: 32319999
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of patients with anemia and renal dysfunction in hospitalized heart failure with preserved ejection fraction (from the CN-HF registry).
Jin X; Cao J; Zhou J; Wang Y; Han X; Song Y; Fan Y; Chen Z; Xu D; Yang X; Dong W; Li L; Chen L; Zhong Q; Fu M; Hu K; Zhou J; Ge J;
Int J Cardiol Heart Vasc; 2019 Dec; 25():100415. PubMed ID: 31508483
[TBL] [Abstract][Full Text] [Related]
34. Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study.
Houchen E; Loefroth E; Schlienger R; Proudfoot C; Corda S; Saha S; Satwase SK; Studer R
Cardiol Ther; 2022 Mar; 11(1):113-127. PubMed ID: 35094306
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF.
Jering KS; Zannad F; Claggett B; Mc Causland FR; Ferreira JP; Desai A; Barkoudah E; McMurray JJV; Pfeffer MA; Solomon SD
JACC Heart Fail; 2021 Jan; 9(1):13-24. PubMed ID: 33189633
[TBL] [Abstract][Full Text] [Related]
36. Frailty increases the long-term risk for fall and fracture-related hospitalizations and all-cause mortality in community-dwelling older women.
Dent E; Dalla Via J; Bozanich T; Hoogendijk EO; Gebre AK; Smith C; Zhu K; Prince RL; Lewis JR; Sim M
J Bone Miner Res; 2024 Apr; 39(3):222-230. PubMed ID: 38477757
[TBL] [Abstract][Full Text] [Related]
37. Beta-Blocker Use and Heart Failure Outcomes in Mildly Reduced and Preserved Ejection Fraction.
Arnold SV; Silverman DN; Gosch K; Nassif ME; Infeld M; Litwin S; Meyer M; Fendler TJ
JACC Heart Fail; 2023 Aug; 11(8 Pt 1):893-900. PubMed ID: 37140513
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Frailty on Long-Term Patient-Oriented Outcomes after Emergency General Surgery: A Retrospective Cohort Study.
Lee KC; Streid J; Sturgeon D; Lipsitz S; Weissman JS; Rosenthal RA; Kim DH; Mitchell SL; Cooper Z
J Am Geriatr Soc; 2020 May; 68(5):1037-1043. PubMed ID: 32043562
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin receptor blockers and outcomes in real-world older patients with heart failure and preserved ejection fraction: a propensity-matched inception cohort clinical effectiveness study.
Patel K; Fonarow GC; Kitzman DW; Aban IB; Love TE; Allman RM; Gheorghiade M; Ahmed A
Eur J Heart Fail; 2012 Oct; 14(10):1179-88. PubMed ID: 22759445
[TBL] [Abstract][Full Text] [Related]
40. Titration of medical therapy and clinical outcomes among patients with heart failure with reduced ejection fraction: Findings from the HF-ACTION trial.
Pierce JB; Mentz RJ; Sun JL; Alhanti B; Whellan DJ; Kraus WE; Piña IL; Fiuzat M; O'Connor CM; Greene SJ
Am Heart J; 2022 Sep; 251():115-126. PubMed ID: 35640729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
